ATTENTION: The software behind KU ScholarWorks is being upgraded to a new version. Starting July 15th, users will not be able to log in to the system, add items, nor make any changes until the new version is in place at the end of July. Searching for articles and opening files will continue to work while the system is being updated.
If you have any questions, please contact Marianne Reed at mreed@ku.edu .
Design, recruitment, and retention of African-American smokers in a pharmacokinetic study
dc.contributor.author | Faseru, Babalola | |
dc.contributor.author | Cox, Lisa S | |
dc.contributor.author | Bronars, Carrie A | |
dc.contributor.author | Opole, Isaac | |
dc.contributor.author | Reed, Gregory A | |
dc.contributor.author | Mayo, Matthew S | |
dc.contributor.author | Ahluwalia, Jasjit S | |
dc.contributor.author | Okuyemi, Kolawole S | |
dc.date.accessioned | 2015-05-27T09:41:09Z | |
dc.date.available | 2015-05-27T09:41:09Z | |
dc.date.issued | 2010-01-19 | en_US |
dc.identifier.uri | http://hdl.handle.net/2271/1322 | en_US |
dc.description.abstract | Abstract Background African-Americans remain underrepresented in clinical research despite experiencing a higher burden of disease compared to all other ethnic groups in the United States. The purpose of this article is to describe the study design and discuss strategies used to recruit and retain African-American smokers in a pharmacokinetic study. Methods The parent study was designed to evaluate the differences in the steady-state concentrations of bupropion and its three principal metabolites between African-American menthol and non-menthol cigarette smokers. Study participation consisted of four visits at a General Clinical Research Center (GCRC) over six weeks. After meeting telephone eligibility requirements, phone-eligible participants underwent additional screening during the first two GCRC visits. The last two visits (pharmacokinetic study phase) required repeated blood draws using an intravenous catheter over the course of 12 hours. Results Five hundred and fifteen African-American smokers completed telephone screening; 187 were phone-eligible and 92 were scheduled for the first GCRC visit. Of the 81 who attended the first visit, 48 individuals were enrolled in the pharmacokinetic study, and a total of 40 individuals completed the study (83% retention rate). Conclusions Although recruitment of African-American smokers into a non-treatment, pharmacokinetic study poses challenges, retention is feasible. The results provide valuable information for investigators embarking on non-treatment laboratory-based studies among minority populations. | |
dc.title | Design, recruitment, and retention of African-American smokers in a pharmacokinetic study | |
dc.type | Article | en_US |
dc.identifier.doi | 10.1186/1471-2288-10-6 | en_US |
dc.date.updated | 2012-07-30T19:07:36Z | |
dc.description.version | Peer Reviewed | |
dc.rights.holder | Babalola Faseru et al.; licensee BioMed Central Ltd. | |
dc.rights.accessrights | openAccess | en_US |
Files in this item
This item appears in the following Collection(s)
-
University of Kansas Medical Center Scholarly Works [77]
KUMC faculty publications from BioMed Central